MediBeacon clears three major regulatory audits without a single finding

The Indianapolis-based firm, which specializes in transdermal measurement and fluorescent tracer agents, faced a grueling schedule of internal reviews, a stage one MDR audit, and a combined assessment covering ISO 13485 and MDSAP certification. Kallen Withers, the project leader who has managed the company's quality systems for five years, noted that the platform’s ability to link disparate documents proved critical during the intense review window.

Unlike legacy paper-based systems that require frantic document retrieval, the digital framework allowed auditors to navigate interconnected records with ease. Withers emphasized that the software’s design—built specifically for the medical device sector rather than adapted from generic enterprise tools—fostered immediate trust with inspectors. As MediBeacon expands its product footprint into the United States and China, the company is now leveraging this established infrastructure to manage design controls for its upcoming product pipeline, citing the platform's stability under regulatory pressure as the foundation for its ongoing growth.